Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04515550 · ClinicalTrials.gov registry record
Mitochondrial Biomarkers in Huntington's Disease
A clinical trial of Huntington Disease, sponsored by University Hospitals Cleveland Medical Center.
- Completed
- Registry status
- 27
- Enrollment target
- 1
- Study location
NCT04515550 is a study of Huntington Disease that has completed, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 27 participants, below the 635-participant average among 35 other Huntington Disease trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04515550, a study of Huntington Disease, has completed, sponsored by University Hospitals Cleveland Medical Center.
- COMPLETED
- Registry status
- 27 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to discover a panel of mitochondrial metabolomics biomarkers for Huntington's disease.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST lumbar puncture
Study Locations (1)
Ohio
- University Hospitals Cleveland Medical Center - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2019-04-04 |
| Est. Completion | 2022-02-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04515550
The ClinicalTrials.gov registry entry for NCT04515550 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 635-participant average among 35 other Huntington Disease trials with a reported enrollment target (96% lower). The listed sponsor is University Hospitals Cleveland Medical Center, which has 230 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Huntington Disease appearing as the primary indexed condition, and to 1 intervention - of which lumbar puncture is the first listed.
NCT04515550 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT04515550 about?
NCT04515550 is a clinical study titled "Mitochondrial Biomarkers in Huntington's Disease". The objective of this study is to discover a panel of mitochondrial metabolomics biomarkers for Huntington's disease.
What is the current status of trial NCT04515550?
This trial is currently completed. The enrollment target is 27 participants. The study started on 2019-04-04. Estimated completion is 2022-02-28.
What conditions does trial NCT04515550 study?
This clinical trial studies the following conditions: Huntington Disease.
What interventions are being tested in trial NCT04515550?
The interventions under investigation include: lumbar puncture (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04515550?
This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04515550 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Huntington Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3)
RECRUITING · NA
-
Longitudinal Endpoint Assessment of Disease Burden in HD
RECRUITING
-
Frequency of Selected Single Nucleotide Polymorphisms in Huntington Disease Gene Expansion Carriers
RECRUITING
-
Extracellular Vesicles for HD
RECRUITING
-
A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease
RECRUITING · Phase 3
-
A Randomized Study of SPK-10001 Gene Therapy in Participants With Huntington's Disease
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.